BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20085115)

  • 1. Neurofibromatosis 2--a family journey.
    Clarke L
    Can J Neurosci Nurs; 2009; 31(4):7-14. PubMed ID: 20085115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
    Evans DG; Baser ME; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson SM; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
    Br J Neurosurg; 2005 Feb; 19(1):5-12. PubMed ID: 16147576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 2: genetic and clinical features.
    Evans DG
    Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis type 2].
    Pérez-Grau M; Miró N; Prades J; Vergés J; Lareo S; Roca-Ribas F
    Acta Otorrinolaringol Esp; 2010; 61(4):306-11. PubMed ID: 20138250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis: a guide to care in the community.
    Redmann C
    J Fam Health Care; 2007; 17(3):95-7. PubMed ID: 17849773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NF2: ocular, neural and genetic manifestations].
    Feucht M; Mautner VF; Richard G
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):312-6. PubMed ID: 15844040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
    Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
    Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management strategies in neurofibromatosis type 2.
    Moffat DA; Quaranta N; Baguley DM; Hardy DG; Chang P
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma development.
    Woods R; Friedman JM; Evans DG; Baser ME; Joe H
    Genet Epidemiol; 2003 May; 24(4):265-72. PubMed ID: 12687643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
    Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
    Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral vestibular schwannomas in older patients: NF2 or chance?
    Evans DG; Freeman S; Gokhale C; Wallace A; Lloyd SK; Axon P; Ward CL; Rutherford S; King A; Huson SM; Ramsden RT;
    J Med Genet; 2015 Jun; 52(6):422-4. PubMed ID: 25725045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.